Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Dig Dis Sci

Retrieve available abstracts of 280 articles:
HTML format



Single Articles


    June 2020
  1. GUTIN LS, Lam AY, Velayos FS, Santos SA, et al
    Going Viral: Management of IBD in the Era of the COVID-19 Pandemic.
    Dig Dis Sci. 2020;65:1571-1575.
    PubMed    


    April 2020
  2. ROTTENSTREICH A, Shifman Z, Grisaru-Granovksy S, Mishael T, et al
    Factors Associated with Inflammatory Bowel Disease Flare During Pregnancy Among Women with Preconception Remission.
    Dig Dis Sci. 2020 Apr 30. pii: 10.1007/s10620-020-06282.
    PubMed     Abstract available


  3. BARBERIO B, Zingone F, Savarino EV
    Inflammatory Bowel Disease and Sleep Disturbance: As Usual, Quality Matters.
    Dig Dis Sci. 2020 Apr 22. pii: 10.1007/s10620-020-06268.
    PubMed    


  4. COBURN ES, Siegel CA, Winter M, Shah ED, et al
    Hemophagocytic Lymphohistiocytosis Occurring in Inflammatory Bowel Disease: Systematic Review.
    Dig Dis Sci. 2020 Apr 16. pii: 10.1007/s10620-020-06252.
    PubMed     Abstract available


  5. WATANABE C, Nagahori M, Fujii T, Yokoyama K, et al
    Non-adherence to Medications in Pregnant Ulcerative Colitis Patients Contributes to Disease Flares and Adverse Pregnancy Outcomes.
    Dig Dis Sci. 2020 Apr 6. pii: 10.1007/s10620-020-06221.
    PubMed     Abstract available


  6. VAN ERP LW, Roosenboom B, Komdeur P, Dijkstra-Heida W, et al
    Improvement of Fatigue and Quality of Life in Patients with Quiescent Inflammatory Bowel Disease Following a Personalized Exercise Program.
    Dig Dis Sci. 2020 Apr 1. pii: 10.1007/s10620-020-06222.
    PubMed     Abstract available


    March 2020
  7. LONGHI MS, Kokkotou E
    Lnc-ing RNA Expression with Disease Pathogenesis: MALAT1 and ANRIL in Ulcerative Colitis.
    Dig Dis Sci. 2020 Mar 30. pii: 10.1007/s10620-020-06216.
    PubMed    


  8. LEE JS, Lee HS, Jang BI, Kim ES, et al
    Low Bone Mineral Density in Young Patients Newly Diagnosed with Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Mar 28. pii: 10.1007/s10620-020-06220.
    PubMed     Abstract available


  9. HAM NS, Hwang SW, Oh EH, Kim J, et al
    Influence of Severe Vitamin D Deficiency on the Clinical Course of Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Mar 26. pii: 10.1007/s10620-020-06207.
    PubMed     Abstract available


  10. GUPTA A, Wash C, Wu Y, Sorrentino D, et al
    Diagnostic Modality of Clostridioides difficile Infection Predicts Treatment Response and Outcomes in Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Mar 23. pii: 10.1007/s10620-020-06205.
    PubMed     Abstract available


  11. FRIAS GOMES C, Narula N, Morao B, Nicola P, et al
    Mode of Delivery Does Not Affect the Risk of Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Mar 21. pii: 10.1007/s10620-020-06204.
    PubMed     Abstract available


  12. CONLEY S, Jeon S, Lehner V, Proctor DD, et al
    Sleep Characteristics and Rest-Activity Rhythms Are Associated with Gastrointestinal Symptoms Among Adults with Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Mar 19. pii: 10.1007/s10620-020-06213.
    PubMed     Abstract available


  13. SYAL G, Robbins L, Kashani A, Bonthala N, et al
    Hypoalbuminemia and Bandemia Predict Failure of Infliximab Rescue Therapy in Acute Severe Ulcerative Colitis.
    Dig Dis Sci. 2020 Mar 13. pii: 10.1007/s10620-020-06177.
    PubMed     Abstract available


  14. GU P, Yang E, Chittajallu P, McNeill C, et al
    Patient Perception and Clinical Impact of Direct-to-Consumer Advertising in Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Mar 7. pii: 10.1007/s10620-020-06180.
    PubMed     Abstract available


  15. JANSSON-KNODELL CL, Harris CE, Loftus EV Jr, Walker RC, et al
    Histoplasmosis in Inflammatory Bowel Disease with Tumor Necrosis Factor-Alpha Inhibitors: Safe to Continue Biologics?
    Dig Dis Sci. 2020 Mar 7. pii: 10.1007/s10620-020-06181.
    PubMed     Abstract available


    February 2020
  16. KO MS, Rudrapatna VA, Avila P, Mahadevan U, et al
    Safety of Flexible Sigmoidoscopy in Pregnant Patients with Known or Suspected Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Feb 7. pii: 10.1007/s10620-020-06122.
    PubMed     Abstract available


  17. ZHU M, Xie J
    LncRNA MALAT1 Promotes Ulcerative Colitis by Upregulating lncRNA ANRIL.
    Dig Dis Sci. 2020 Feb 5. pii: 10.1007/s10620-020-06093.
    PubMed     Abstract available


    January 2020
  18. LIMSRIVILAI J, Saleh ZM, Johnson LA, Stidham RW, et al
    Prevalence and Effect of Intestinal Infections Detected by a PCR-Based Stool Test in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Jan 24. pii: 10.1007/s10620-020-06071.
    PubMed     Abstract available


  19. LAZARO CM, de Oliveira CC, Gambero A, Rocha T, et al
    Evaluation of Budesonide-Hydroxypropyl-beta-Cyclodextrin Inclusion Complex in Thermoreversible Gels for Ulcerative Colitis.
    Dig Dis Sci. 2020 Jan 23. pii: 10.1007/s10620-020-06075.
    PubMed     Abstract available


  20. BERNARD EJ, Fedorak RN, Jairath V
    Systematic Review: Non-medical Switching of Infliximab to CT-P13 in Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Jan 22. pii: 10.1007/s10620-019-06036.
    PubMed     Abstract available


  21. GIBSON DJ, Doherty GA
    Fast and Curious: An Algorithmic Approach to Infliximab Dosing in Acute Severe Ulcerative Colitis.
    Dig Dis Sci. 2020 Jan 22. pii: 10.1007/s10620-020-06084.
    PubMed    


  22. BARRETT KE
    DRAwing Conclusions About the Basis of Diarrhea in Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Jan 16. pii: 10.1007/s10620-020-06060.
    PubMed    


  23. STATES V, O'Brien S, Rai JP, Roberts HL, et al
    Pyoderma Gangrenosum in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2020 Jan 10. pii: 10.1007/s10620-019-05999.
    PubMed     Abstract available


  24. SATYAM VR, Li PH, Reich J, Qazi T, et al
    Safety of Recombinant Zoster Vaccine in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2020 Jan 2. pii: 10.1007/s10620-019-06016.
    PubMed     Abstract available


    December 2019
  25. TORRES P, Canete F, Nunez L, Aguilar A, et al
    Spacing the Administration Interval of Anti-TNF Agents: A Valid Strategy for Patients with Inflammatory Bowel Disease?
    Dig Dis Sci. 2019 Dec 19. pii: 10.1007/s10620-019-06010.
    PubMed     Abstract available


  26. GUBATAN J, Triadafilopoulos G, Fernandez-Becker NQ
    Double Threat: Interplay of Celiac Disease with Inflammatory Bowel Disease.
    Dig Dis Sci. 2019 Dec 11. pii: 10.1007/s10620-019-05994.
    PubMed    


  27. BILGRAMI Z, Abutaleb A, Chudy-Onwugaje K, Langenberg P, et al
    Correction to: Effect of TELEmedicine for Inflammatory Bowel Disease on Patient Activation and Self-Efficacy.
    Dig Dis Sci. 2019 Dec 2. pii: 10.1007/s10620-019-05953.
    PubMed     Abstract available


    November 2019
  28. SONNENBERG A, Turner KO, Genta RM
    Upper Gastrointestinal Disease Influences the Occurrence of Inflammatory Bowel Disease.
    Dig Dis Sci. 2019 Nov 27. pii: 10.1007/s10620-019-05972.
    PubMed     Abstract available


  29. GU P, Patel D, Lakhoo K, Ko J, et al
    Breath Test Gas Patterns in Inflammatory Bowel Disease with Concomitant Irritable Bowel Syndrome-Like Symptoms: A Controlled Large-Scale Database Linkage Analysis.
    Dig Dis Sci. 2019 Nov 21. pii: 10.1007/s10620-019-05967.
    PubMed     Abstract available


  30. BERTANI L, Bodini G, Mumolo MG, de Bortoli N, et al
    Corticosteroid Treatment at Diagnosis: An Analysis of Relapses, Disease Extension, and Colectomy Rate in Ulcerative Colitis.
    Dig Dis Sci. 2019 Nov 21. pii: 10.1007/s10620-019-05959.
    PubMed     Abstract available


  31. GOVANI SM, Berinstein JA, Waljee AK, Stidham RW, et al
    Use of Accelerated Induction Strategy of Infliximab for Ulcerative Colitis in Hospitalized Patients at a Tertiary Care Center.
    Dig Dis Sci. 2019 Nov 20. pii: 10.1007/s10620-019-05957.
    PubMed     Abstract available


  32. BOSSA F, Biscaglia G, Valvano MR, Costantino G, et al
    Real-Life Effectiveness and Safety of Golimumab and Its Predictors of Response in Patients with Ulcerative Colitis.
    Dig Dis Sci. 2019 Nov 13. pii: 10.1007/s10620-019-05904.
    PubMed     Abstract available


  33. KIM J, Feagins LA
    Managing Patients with Inflammatory Bowel Disease Who Develop Prostate Cancer.
    Dig Dis Sci. 2019 Nov 11. pii: 10.1007/s10620-019-05934.
    PubMed     Abstract available


  34. BOPARAI ES, Velayos FS, Roy A, Li C, et al
    Elevating the Technique: Resecting Complex Dysplastic Lesions of the Colon in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2019 Nov 9. pii: 10.1007/s10620-019-05931.
    PubMed    


  35. PAI YC, Yu LC
    Is "Cholinergic" Stimulus Useful for Ulcerative Colitis Treatment?
    Dig Dis Sci. 2019 Nov 7. pii: 10.1007/s10620-019-05933.
    PubMed    


  36. JUNG YS, Han M, Park S, Cheon JH, et al
    Biologic Use Patterns and Predictors for Non-persistence and Switching of Biologics in Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Study.
    Dig Dis Sci. 2019 Nov 1. pii: 10.1007/s10620-019-05867.
    PubMed     Abstract available


    October 2019
  37. BERRY SK, Takakura W, Bresee C, Melmed GY, et al
    Pain in Inflammatory Bowel Disease Is Not Improved During Hospitalization: The Impact of Opioids on Pain and Healthcare Utilization.
    Dig Dis Sci. 2019 Oct 25. pii: 10.1007/s10620-019-05906.
    PubMed     Abstract available


  38. SINGH SP, Chand HS, Banerjee S, Agarwal H, et al
    Acetylcholinesterase Inhibitor Pyridostigmine Bromide Attenuates Gut Pathology and Bacterial Dysbiosis in a Murine Model of Ulcerative Colitis.
    Dig Dis Sci. 2019 Oct 23. pii: 10.1007/s10620-019-05838.
    PubMed     Abstract available


    September 2019
  39. JANG J, Kwok B, Zhong H, Xia Y, et al
    Alvimopan for the Prevention of Postoperative Ileus in Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2019 Sep 14. pii: 10.1007/s10620-019-05839.
    PubMed     Abstract available


  40. RIVIERE P, Laharie D, Marteau P
    Concise Commentary: Second Line Is Not Second Best-Continuing Validity of the Oxford Criteria in the Management of Acute Severe Ulcerative Colitis.
    Dig Dis Sci. 2019 Sep 5. pii: 10.1007/s10620-019-05788.
    PubMed    


  41. LIATSOS C, Papaefthymiou A, Tzouvala M, Doulberis M, et al
    Current Aspects on Differentiating Relapses from Over-Infections in Symptomatic Inflammatory Bowel Diseases.
    Dig Dis Sci. 2019;64:2686-2687.
    PubMed    


  42. PAREDES JM, Moreno N, Latorre P, Ripolles T, et al
    Clinical Impact of Sonographic Transmural Healing After Anti-TNF Antibody Treatment in Patients with Crohn's Disease.
    Dig Dis Sci. 2019;64:2600-2606.
    PubMed     Abstract available


    August 2019
  43. NAFTALI T
    Is Cannabis of Potential Value as a Therapeutic for Inflammatory Bowel Disease?
    Dig Dis Sci. 2019 Aug 6. pii: 10.1007/s10620-019-05763.
    PubMed    


  44. ABDALLA M, Norblad R, Olsson M, Landerholm K, et al
    Anorectal Function After Ileo-Rectal Anastomosis Is Better than Pelvic Pouch in Selected Ulcerative Colitis Patients.
    Dig Dis Sci. 2019 Aug 1. pii: 10.1007/s10620-019-05757.
    PubMed     Abstract available


  45. BURKE KE, Nayor J, Campbell EJ, Ananthakrishnan AN, et al
    Interval Colorectal Cancer in Inflammatory Bowel Disease: The Role of Guideline Adherence.
    Dig Dis Sci. 2019 Aug 1. pii: 10.1007/s10620-019-05754.
    PubMed     Abstract available


  46. WATANABE Y, Miyoshi N, Fujino S, Takahashi H, et al
    Cumulative Inflammation Could Be a Risk Factor for Intestinal Failure in Crohn's Disease.
    Dig Dis Sci. 2019;64:2280-2285.
    PubMed     Abstract available


    July 2019
  47. CHANG JY, Cheon JH
    Thiopurine Therapy in Patients With Inflammatory Bowel Disease: A Focus on Metabolism and Pharmacogenetics.
    Dig Dis Sci. 2019 Jul 9. pii: 10.1007/s10620-019-05720.
    PubMed     Abstract available


  48. WASZCZUK L, Waszczuk K, Waszczuk E
    CT in Crohn's Disease Is Beneficial for Patient Care and Should Not Be Feared.
    Dig Dis Sci. 2019;64:2056-2058.
    PubMed    


  49. CLARK-SNUSTAD KD, Singla A, Lee SD
    Efficacy of Infliximab in Crohn's Disease Patients with Prior Primary-Nonresponse to Tumor Necrosis Factor Antagonists.
    Dig Dis Sci. 2019;64:1952-1958.
    PubMed     Abstract available


  50. WEISSHOF R, Aharoni Golan M, Sossenheimer PH, El Jurdi K, et al
    Real-World Experience with Tofacitinib in IBD at a Tertiary Center.
    Dig Dis Sci. 2019;64:1945-1951.
    PubMed     Abstract available


  51. SCHAD CA, Haac BE, Cross RK, Syed A, et al
    Early Postoperative Anti-TNF Therapy Does Not Increase Complications Following Abdominal Surgery in Crohn's Disease.
    Dig Dis Sci. 2019;64:1959-1966.
    PubMed     Abstract available


    June 2019
  52. PAPAMICHAEL K, Cheifetz AS
    Integrin Calculus: The Predictive Power of Vedolizumab Concentrations in IBD Therapy.
    Dig Dis Sci. 2019;64:1397-1398.
    PubMed    


  53. ANNESE V
    Biosimilars in IBD: Similarity Breeds Contented Patients.
    Dig Dis Sci. 2019;64:1399-1400.
    PubMed    


  54. YARUR AJ, Bruss A, Naik S, Beniwal-Patel P, et al
    Vedolizumab Concentrations Are Associated with Long-Term Endoscopic Remission in Patients with Inflammatory Bowel Diseases.
    Dig Dis Sci. 2019;64:1651-1659.
    PubMed     Abstract available


  55. MARTINEZ MJ, Ripolles T, Paredes JM, Moreno-Osset E, et al
    Intravenous Contrast-Enhanced Ultrasound for Assessing and Grading Postoperative Recurrence of Crohn's Disease.
    Dig Dis Sci. 2019;64:1640-1650.
    PubMed     Abstract available


  56. VASUDEVAN A, Raghunath A, Anthony S, Scanlon C, et al
    Higher Mucosal Healing with Tumor Necrosis Factor Inhibitors in Combination with Thiopurines Compared to Methotrexate in Crohn's Disease.
    Dig Dis Sci. 2019;64:1622-1631.
    PubMed     Abstract available


  57. PLEVRIS N, Jones GR, Jenkinson PW, Lyons M, et al
    Implementation of CT-P13 via a Managed Switch Programme in Crohn's Disease: 12-Month Real-World Outcomes.
    Dig Dis Sci. 2019;64:1660-1667.
    PubMed     Abstract available


    May 2019
  58. JIANG JX, Keat K, Swaminathan S
    ANCA-Associated Vasculitis in Inflammatory Bowel Disease.
    Dig Dis Sci. 2019 May 15. pii: 10.1007/s10620-019-05654.
    PubMed    


  59. TSIAOUSSIS GI, Assimakopoulos SF, Thomopoulos KC
    The Writing Is on the Wall: The Utility of Mural Stratification for Risk Stratification of Hospitalized Patients with Severe Ulcerative Colitis.
    Dig Dis Sci. 2019 May 15. pii: 10.1007/s10620-019-05672.
    PubMed    


  60. MOORE AC, Bressler B
    Acute Severe Ulcerative Colitis: The Oxford Criteria No Longer Predict In-Hospital Colectomy Rates.
    Dig Dis Sci. 2019 May 15. pii: 10.1007/s10620-019-05668.
    PubMed     Abstract available


  61. LEY D, Hayney MS, Caldera F
    Third Time's a Charm: Immunization Strategies for Hepatitis B in Immunosuppressed Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2019 May 11. pii: 10.1007/s10620-019-05662.
    PubMed    


  62. ZHAO M, Burisch J
    Impact of Genes and the Environment on the Pathogenesis and Disease Course of Inflammatory Bowel Disease.
    Dig Dis Sci. 2019 May 9. pii: 10.1007/s10620-019-05648.
    PubMed     Abstract available


  63. SULTAN K, Shah D, Bhorania K, Zhou E, et al
    Increased Transfusion Requirements with Pharmacologic Thromboembolism Prophylaxis During Inflammatory Bowel Disease Exacerbation.
    Dig Dis Sci. 2019 May 7. pii: 10.1007/s10620-019-05650.
    PubMed     Abstract available


  64. NGUYEN VQ, Sorrentino D
    Diagnostic and Therapeutic Delays in the Management of Postoperative Crohn's Disease.
    Dig Dis Sci. 2019;64:1388-1389.
    PubMed    


  65. GHOSH S, Bressler B, Petkau J, Thakkar RB, et al
    Healthcare Providers Underestimate Patients' Glucocorticoid Use in Crohn's Disease.
    Dig Dis Sci. 2019;64:1142-1149.
    PubMed     Abstract available


    April 2019
  66. LEE H, Schneider Y, Lichtenstein GR
    Going Third Class: Treatment of Steroid-Dependent Ulcerative Colitis.
    Dig Dis Sci. 2019 Apr 24. pii: 10.1007/s10620-019-05610.
    PubMed    


  67. PRATT PK JR, Nunes D, Long MT, Farraye FA, et al
    Improved Antibody Response to Three Additional Hepatitis B Vaccine Doses Following Primary Vaccination Failure in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2019 Apr 3. pii: 10.1007/s10620-019-05595.
    PubMed     Abstract available


    March 2019
  68. DULAI PS, Osterman MT, Lasch K, Cao C, et al
    Market Access Analysis of Biologics and Small-Molecule Inhibitors for Inflammatory Bowel Disease Among US Health Insurance Policies.
    Dig Dis Sci. 2019 Mar 28. pii: 10.1007/s10620-019-05594.
    PubMed     Abstract available


  69. ADLER E, Tabaa A, Kassam Z, Zydek M, et al
    Capsule-Delivered Fecal Microbiota Transplant Is Safe and Well Tolerated in Patients with Ulcerative Colitis.
    Dig Dis Sci. 2019 Mar 27. pii: 10.1007/s10620-019-05596.
    PubMed    


  70. QURESHI T, Peter Nguyen T, Wang R, Willis D, et al
    Improving Anemia in Inflammatory Bowel Disease: Impact of the Anemia Care Pathway.
    Dig Dis Sci. 2019 Mar 16. pii: 10.1007/s10620-019-05559.
    PubMed     Abstract available


  71. DAI C, Jiang M, Sun MJ
    High-Dose Infliximab Rescue Therapy for Hospitalized Acute Severe Ulcerative Colitis.
    Dig Dis Sci. 2019 Mar 4. pii: 10.1007/s10620-019-05531.
    PubMed    


  72. GORDON N, Sebastian S
    Real-World Success of Biologic Therapy in IBD: No More Reasons to Be Anti Antibody.
    Dig Dis Sci. 2019;64:614-615.
    PubMed    


  73. SUAREZ FERRER C, Gonzalez-Lama Y, Gonzalez-Partida I, Calvo Moya M, et al
    Usefulness of Thiopurine Monotherapy for Crohn's Disease in the Era of Biologics: A Long-Term Single-Center Experience.
    Dig Dis Sci. 2019;64:875-879.
    PubMed     Abstract available


  74. CHECKLEY LA, Kristofek L, Kile S, Bolgar W, et al
    Incidence and Management of Infusion Reactions to Infliximab in an Alternate Care Setting.
    Dig Dis Sci. 2019;64:855-862.
    PubMed     Abstract available


    February 2019
  75. KOSLOWSKY B, Sadeh C, Grisaru-Granovsky S, Miskin H, et al
    Thiopurine Therapy for Inflammatory Bowel Disease During Pregnancy Is Not Associated with Anemia in the Infant.
    Dig Dis Sci. 2019 Feb 28. pii: 10.1007/s10620-019-05555.
    PubMed     Abstract available


  76. COHEN-MEKELBURG S, Schneider Y, Gold S, Ghosh G, et al
    Risk of Early Colorectal Cancers Needs to Be Considered in Inflammatory Bowel Disease Care.
    Dig Dis Sci. 2019 Feb 28. pii: 10.1007/s10620-019-05554.
    PubMed     Abstract available


  77. CUSHING KC, Kordbacheh H, Gee MS, Kambadakone A, et al
    CT-Visualized Colonic Mural Stratification Independently Predicts the Need for Medical or Surgical Rescue Therapy in Hospitalized Ulcerative Colitis Patients.
    Dig Dis Sci. 2019 Feb 22. pii: 10.1007/s10620-019-05520.
    PubMed     Abstract available


  78. LIU JJ, Rosson TB, Xie JJ, Harris ZP, et al
    Personalized Inflammatory Bowel Disease Care Reduced Hospitalizations.
    Dig Dis Sci. 2019 Feb 12. pii: 10.1007/s10620-019-05485.
    PubMed     Abstract available


  79. XU F, Dahlhamer JM, Terlizzi EP, Wheaton AG, et al
    Receipt of Preventive Care Services Among US Adults with Inflammatory Bowel Disease, 2015-2016.
    Dig Dis Sci. 2019 Feb 12. pii: 10.1007/s10620-019-05494.
    PubMed     Abstract available


  80. KIM DW, An JM, Hong SP, Hahm KB, et al
    Predictive Value of Procalcitonin in Acute Severe Ulcerative Colitis: Not Quite PerfeCT?
    Dig Dis Sci. 2019 Feb 7. pii: 10.1007/s10620-019-05481.
    PubMed    


  81. DEVA RAJOO G, Tan L, Lopez A, Lewindon P, et al
    Early Response to Corticosteroid and Baseline C-Reactive Protein Predicts Outcomes in Children with Moderate to Severe Ulcerative Colitis.
    Dig Dis Sci. 2019 Feb 7. pii: 10.1007/s10620-019-05486.
    PubMed     Abstract available


  82. PERERA LP, Radigan M, Guilday C, Banerjee I, et al
    Presence of Irritable Bowel Syndrome Symptoms in Quiescent Inflammatory Bowel Disease Is Associated with High Rate of Anxiety and Depression.
    Dig Dis Sci. 2019 Feb 6. pii: 10.1007/s10620-019-05488.
    PubMed     Abstract available


  83. MOSADEGHI S, Taleban S
    Alternate Settings for Infusions in Inflammatory Bowel Disease Patients: Homing in on Optimal Care.
    Dig Dis Sci. 2019 Feb 6. pii: 10.1007/s10620-019-05480.
    PubMed    


  84. JACOBS JD, Wagner T, Gulotta G, Liao C, et al
    Impact of Angiotensin II Signaling Blockade on Clinical Outcomes in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2019 Feb 6. pii: 10.1007/s10620-019-5474.
    PubMed     Abstract available


  85. MENG Y, Li Y, Hao R, Li X, et al
    Analysis of Phenotypic Variables and Differentiation Between Untypical Crohn's Disease and Untypical Intestinal Tuberculosis.
    Dig Dis Sci. 2019 Feb 6. pii: 10.1007/s10620-019-05491.
    PubMed     Abstract available


  86. ZHAO S, Wang J, Zhao Z
    Inflammatory Bowel Diseases and Sexual Health: More Studies Are Needed.
    Dig Dis Sci. 2019;64:594-595.
    PubMed    


  87. MITSIALIS V, Wu Y, Gewurz B, Bleday R, et al
    Raising the Barr: An Unexpected Lesion at Ileal-Cecal Resection.
    Dig Dis Sci. 2019;64:353-357.
    PubMed    


  88. IRWIN JR, Ferguson E, Simms LA, Hanigan K, et al
    Detectable Laboratory Abnormality Is Present up to 12 Months Prior to Diagnosis in Patients with Crohn's Disease.
    Dig Dis Sci. 2019;64:503-517.
    PubMed     Abstract available


  89. AHMAD W, Nguyen NH, Boland BS, Dulai PS, et al
    Comparison of Multiplex Gastrointestinal Pathogen Panel and Conventional Stool Testing for Evaluation of Diarrhea in Patients with Inflammatory Bowel Diseases.
    Dig Dis Sci. 2019;64:382-390.
    PubMed     Abstract available


    January 2019
  90. AMORIM RF, Viegas ERC, Carneiro AJV, Esberard BC, et al
    Superiority of Interferon Gamma Assay Over Tuberculin Skin Test for Latent Tuberculosis in Inflammatory Bowel Disease Patients in Brazil.
    Dig Dis Sci. 2019 Jan 23. pii: 10.1007/s10620-019-5475.
    PubMed     Abstract available


  91. WU HM, Wei J, Li J, Wang K, et al
    Serum Procalcitonin as a Potential Early Predictor of Short-Term Outcomes in Acute Severe Ulcerative Colitis.
    Dig Dis Sci. 2019 Jan 2. pii: 10.1007/s10620-018-5446.
    PubMed     Abstract available


  92. BILGRAMI Z, Abutaleb A, Chudy-Onwugaje K, Langenberg P, et al
    Effect of TELEmedicine for Inflammatory Bowel Disease on Patient Activation and Self-Efficacy.
    Dig Dis Sci. 2019 Jan 2. pii: 10.1007/s10620-018-5433.
    PubMed     Abstract available


  93. IBORRA M, Herreras J, Bosca-Watts MM, Cortes X, et al
    Withdrawal of Azathioprine in Inflammatory Bowel Disease Patients Who Sustain Remission: New Risk Factors for Relapse.
    Dig Dis Sci. 2019 Jan 2. pii: 10.1007/s10620-018-5429.
    PubMed     Abstract available


  94. NOCERINO A, Feathers A, Ivanina E, Durbin L, et al
    Mortality Risk of Inflammatory Bowel Disease: A Case-Control Study of New York State Death Records.
    Dig Dis Sci. 2019 Jan 2. pii: 10.1007/s10620-018-5430.
    PubMed     Abstract available


  95. FIELDS AC, Melnitchouk N
    Medical Prophylaxis of Post-Surgical Crohn's Disease Recurrence: Towards Timely Anti-TNF Therapy.
    Dig Dis Sci. 2019;64:7-8.
    PubMed    


  96. VELAYOS F
    Introduction to the IBD Case Conference Series.
    Dig Dis Sci. 2019;64:50-51.
    PubMed    


  97. PATIL SA, Flasar MH, Lin J, Lingohr-Smith M, et al
    Reduced Imaging Radiation Exposure and Costs Associated with Anti-Tumor Necrosis Factor Therapy in Crohn's Disease.
    Dig Dis Sci. 2019;64:60-67.
    PubMed     Abstract available


  98. ALTHOFF P, Schmiegel W, Lang G, Nicolas V, et al
    Creeping Fat Assessed by Small Bowel MRI Is Linked to Bowel Damage and Abdominal Surgery in Crohn's Disease.
    Dig Dis Sci. 2019;64:204-212.
    PubMed     Abstract available


  99. COHEN-MEKELBURG S, Gold S, Schneider Y, Dennis M, et al
    Delays in Initiating Post-operative Prophylactic Biologic Therapy Are Common Among Crohn's Disease Patients.
    Dig Dis Sci. 2019;64:196-203.
    PubMed     Abstract available


    December 2018
  100. SHRESTHA MP, Taleban S
    Obesity Is Associated with Increased Risk of Colectomy in Inflammatory Bowel Disease Patients Hospitalized with Clostridium difficile Infection.
    Dig Dis Sci. 2018 Dec 19. pii: 10.1007/s10620-018-5423.
    PubMed     Abstract available


  101. LEWIN SM, Wen KW, Velayos FS, Mahadevan U, et al
    How Dye May Prevent Dying from Cancer: Perceiving Imperceptible Dysplasia in Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Dec 7. pii: 10.1007/s10620-018-5409.
    PubMed    


  102. HAKIM S, Ramireddy S, Amin M, Gebara S, et al
    Preoperative Misdiagnosis of Intestinal Behcet's Syndrome as Crohn's Disease Based on Superficial Colonoscopic Biopsies: Case Report and Systematic Review.
    Dig Dis Sci. 2018;63:3509-3515.
    PubMed    


  103. BIAN Y, Liu P, Zhong J, Hu Y, et al
    Quercetin Attenuates Adhesion Molecule Expression in Intestinal Microvascular Endothelial Cells by Modulating Multiple Pathways.
    Dig Dis Sci. 2018;63:3297-3304.
    PubMed     Abstract available


  104. GAO X, Li J, Chen M
    Effect of Homocysteine on the Differentiation of CD4(+) T Cells into Th17 Cells.
    Dig Dis Sci. 2018;63:3339-3347.
    PubMed     Abstract available


    November 2018
  105. BAJPAI M, Seril DN, Van Gurp J, Geng X, et al
    Effect of Long-Term Mesalamine Therapy on Cancer-Associated Gene Expression in Colonic Mucosa of Patients with Ulcerative Colitis.
    Dig Dis Sci. 2018 Nov 26. pii: 10.1007/s10620-018-5378.
    PubMed     Abstract available


  106. CHAO CY, Khoury AA, Aruljothy A, Restellini S, et al
    High-Dose Infliximab Rescue Therapy for Hospitalized Acute Severe Ulcerative Colitis Does Not Improve Colectomy-Free Survival.
    Dig Dis Sci. 2018 Nov 16. pii: 10.1007/s10620-018-5358.
    PubMed     Abstract available


  107. CHAPARRO M, Barreiro-de Acosta M, Echarri A, Almendros R, et al
    Correlation Between Anti-TNF Serum Levels and Endoscopic Inflammation in Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2018 Nov 13. pii: 10.1007/s10620-018-5362.
    PubMed     Abstract available


    October 2018
  108. SARTINI A, Scaioli E, Liverani E, Bellanova M, et al
    Retention Rate, Persistence and Safety of Adalimumab in Inflammatory Bowel Disease: A Real-Life, 9-Year, Single-Center Experience in Italy.
    Dig Dis Sci. 2018 Oct 17. pii: 10.1007/s10620-018-5329.
    PubMed     Abstract available


  109. MILLER M, Vu KN, Zemek A, Shelton A, et al
    TB or Not TB: Crohn's Disease, Peritoneal Tuberculosis, or Both?
    Dig Dis Sci. 2018 Oct 17. pii: 10.1007/s10620-018-5334.
    PubMed    


  110. CALDERA F, Misch EA, Saha S, Wald A, et al
    Immunosuppression Does Not Affect Antibody Concentrations to Measles, Mumps, and Rubella in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Oct 13. pii: 10.1007/s10620-018-5321.
    PubMed     Abstract available


  111. MA C, Ascoytia C, McCarrier KP, Martin M, et al
    Physicians' Perspectives on Cost, Safety, and Perceived Efficacy Determine Aminosalicylate Use in Crohn's Disease.
    Dig Dis Sci. 2018;63:2555-2563.
    PubMed     Abstract available


  112. NASSER Y, Labetoulle R, Harzallah I, Berger AE, et al
    Comparison of Point-of-Care and Classical Immunoassays for the Monitoring Infliximab and Antibodies Against Infliximab in IBD.
    Dig Dis Sci. 2018;63:2714-2721.
    PubMed     Abstract available


  113. KEDIA S, Jain S, Goyal S, Bopanna S, et al
    Potential of Fecal Calprotectin as an Objective Marker to Discriminate Hospitalized Patients with Acute Severe Colitis from Outpatients with Less Severe Disease.
    Dig Dis Sci. 2018;63:2747-2753.
    PubMed     Abstract available


  114. PATIL SA, Cross RK
    More Skin in the Game: Screening for Skin Cancer in IBD Patients.
    Dig Dis Sci. 2018;63:2497-2499.
    PubMed    


  115. LEE D, Swan CK, Suskind D, Wahbeh G, et al
    Children with Crohn's Disease Frequently Consume Select Food Additives.
    Dig Dis Sci. 2018;63:2722-2728.
    PubMed     Abstract available


    September 2018
  116. CHIOCCHETTI A, Prodam F, Dianzani U
    Homocysteine and Folate in Inflammatory Bowel Disease: Can Reducing Sulfur Reduce Suffering?
    Dig Dis Sci. 2018 Sep 6. pii: 10.1007/s10620-018-5274.
    PubMed    


  117. SCHIFF ER, Frampton M, Semplici F, Bloom SL, et al
    A New Look at Familial Risk of Inflammatory Bowel Disease in the Ashkenazi Jewish Population.
    Dig Dis Sci. 2018 Sep 3. pii: 10.1007/s10620-018-5219.
    PubMed     Abstract available


  118. FIORUCCI S, Biagioli M, Distrutti E
    Immunephenotype Predicts Response to Vedolizumab: Integrating Clinical and Biochemical Biomarkers in the Treatment of Inflammatory Bowel Diseases.
    Dig Dis Sci. 2018;63:2168-2171.
    PubMed    


  119. KIM ES, Kim SK, Jang BI, Kim KO, et al
    Disease Activity Patterns Recorded Using a Mobile Monitoring System Are Associated with Clinical Outcomes of Patients with Crohn's Disease.
    Dig Dis Sci. 2018;63:2220-2230.
    PubMed     Abstract available


    August 2018
  120. SHIN DS, Cheon JH, Park YE, Park Y, et al
    Extensive Disease Subtypes in Adult Patients with Ulcerative Colitis: Non-pancolitis Versus Pancolitis.
    Dig Dis Sci. 2018 Aug 25. pii: 10.1007/s10620-018-5218.
    PubMed     Abstract available


  121. MICIC D, Yarur A, Gonsalves A, Rao VL, et al
    Correction to: Risk Factors for Clostridium difficile Isolation in Inflammatory Bowel Disease: A Prospective Study.
    Dig Dis Sci. 2018 Aug 22. pii: 10.1007/s10620-018-5249.
    PubMed     Abstract available


  122. LI Y, Xu H, Xu T, Xiao M, et al
    Case-Control Study of Inflammatory Bowel Disease Patients with and without Clostridium difficile Infection and Poor Outcomes in Patients Coinfected with C. difficile and Cytomegalovirus.
    Dig Dis Sci. 2018 Aug 9. pii: 10.1007/s10620-018-5230.
    PubMed     Abstract available


    July 2018
  123. CHABLANI SV, Ramos-Rivers C, Binion DG, Szigethy E, et al
    Depressive Symptoms Predict Anti-tumor Necrosis Factor Therapy Noncompliance and Healthcare Utilization in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Jul 19. pii: 10.1007/s10620-018-5194.
    PubMed    


  124. BAR-GIL SHITRIT A, Chen-Shuali C, Adar T, Koslowsky B, et al
    Sleep Disturbances Can Be Prospectively Observed in Patients with an Inactive Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Jul 19. pii: 10.1007/s10620-018-5207.
    PubMed     Abstract available


  125. JUNCADELLA A, Papamichael K, Vaughn BP, Cheifetz AS, et al
    Maintenance Adalimumab Concentrations Are Associated with Biochemical, Endoscopic, and Histologic Remission in Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Jul 13. pii: 10.1007/s10620-018-5202.
    PubMed     Abstract available


  126. CHANG JY, Cheon JH, Park Y, Park SJ, et al
    Does Medical Acceleration Improve Outcomes in Ulcerative Colitis Patients Who Are in Clinical Remission but Have Endoscopic Inflammation?
    Dig Dis Sci. 2018 Jul 9. pii: 10.1007/s10620-018-5193.
    PubMed     Abstract available


  127. SITKIN S, Pokrotnieks J
    Alterations in Polyunsaturated Fatty Acid Metabolism and Reduced Serum Eicosadienoic Acid Level in Ulcerative Colitis: Is There a Place for Metabolomic Fatty Acid Biomarkers in IBD?
    Dig Dis Sci. 2018 Jul 9. pii: 10.1007/s10620-018-5182.
    PubMed    


  128. DAMAS OM, Estes D, Avalos D, Quintero MA, et al
    Hispanics Coming to the US Adopt US Cultural Behaviors and Eat Less Healthy: Implications for Development of Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Jul 7. pii: 10.1007/s10620-018-5185.
    PubMed     Abstract available


  129. AL-TAWEEL T, Strohl M, Pai M, Martel M, et al
    A Study of Optimal Screening for Latent Tuberculosis in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Jul 3. pii: 10.1007/s10620-018-5178.
    PubMed     Abstract available


  130. LING C, Gavin M, Hanson J, McCarthy DM, et al
    Progressive Epigastric Pain with Abnormal Liver Tests in a Patient with Crohn's Disease: Don't DILI Dally.
    Dig Dis Sci. 2018;63:1751-1755.
    PubMed    


  131. LIAN L, Huang Q, Zhang L, Qin H, et al
    Anti-fibrogenic Potential of Mesenchymal Stromal Cells in Treating Fibrosis in Crohn's Disease.
    Dig Dis Sci. 2018;63:1821-1834.
    PubMed     Abstract available


    June 2018
  132. ZHU H, Huang S, Yue M, Chen W, et al
    Dysregulated Up-Frameshift Protein 1 Promotes Ulcerative Colitis Pathogenesis Through the TNFR1-NF-kappaB/MAPKs Pathway.
    Dig Dis Sci. 2018 Jun 29. pii: 10.1007/s10620-018-5171.
    PubMed     Abstract available


  133. VEDAMURTHY A, Xu L, Luther J, Colizzo F, et al
    Long-Term Outcomes of Immunosuppression-Naive Steroid Responders Following Hospitalization for Ulcerative Colitis.
    Dig Dis Sci. 2018 Jun 27. pii: 10.1007/s10620-018-5176.
    PubMed     Abstract available


  134. ANDERSON AJM, Ferris LK, Binion DG, Smith KJ, et al
    Cost-Effectiveness of Melanoma Screening in Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Jun 13. pii: 10.1007/s10620-018-5141.
    PubMed     Abstract available


  135. WANG P, Hu J, Ghadermarzi S, Raza A, et al
    Smoking and Inflammatory Bowel Disease: A Comparison of China, India, and the USA.
    Dig Dis Sci. 2018 Jun 4. pii: 10.1007/s10620-018-5142.
    PubMed     Abstract available


  136. ARORA U, Kedia S, Garg P, Bopanna S, et al
    Colonic Crohn's Disease Is Associated with Less Aggressive Disease Course Than Ileal or Ileocolonic Disease.
    Dig Dis Sci. 2018;63:1592-1599.
    PubMed     Abstract available


  137. ELURI S, Cross RK, Martin C, Weinfurt KP, et al
    Inflammatory Bowel Diseases Can Adversely Impact Domains of Sexual Function Such as Satisfaction with Sex Life.
    Dig Dis Sci. 2018;63:1572-1582.
    PubMed     Abstract available


  138. KOK B, Lester ELW, Lee WM, Hanje AJ, et al
    Acute Liver Failure from Tumor Necrosis Factor-alpha Antagonists: Report of Four Cases and Literature Review.
    Dig Dis Sci. 2018;63:1654-1666.
    PubMed     Abstract available


    May 2018
  139. ABRAHAM BP, Quigley EMM
    A Probiotic for Ulcerative Colitis: The Culture Wars Continue.
    Dig Dis Sci. 2018 May 21. pii: 10.1007/s10620-018-5097.
    PubMed    


  140. CHANDRADAS S, Khalili H, Ananthakrishnan A, Wayman C, et al
    Does Obesity Influence the Risk of Clostridium difficile Infection Among Patients with Ulcerative Colitis?
    Dig Dis Sci. 2018 May 19. pii: 10.1007/s10620-018-5108.
    PubMed     Abstract available


  141. COHEN-MEKELBURG S, Tafesh Z, Coburn E, Weg R, et al
    Testing and Treating Small Intestinal Bacterial Overgrowth Reduces Symptoms in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 May 14. pii: 10.1007/s10620-018-5109.
    PubMed     Abstract available


  142. WEIZMAN AV, Sharma R, Afzal NM, Xu W, et al
    Stricturing and Fistulizing Crohn's Disease Is Associated with Anti-tumor Necrosis Factor-Induced Psoriasis in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 May 8. pii: 10.1007/s10620-018-5096.
    PubMed     Abstract available


  143. UZZAN M
    Concise Commentary: Calling in Your Marker-Rectal CD30-Positive Cells Differentiate Ulcerative Colitis from Crohn's Disease.
    Dig Dis Sci. 2018 May 3. pii: 10.1007/s10620-018-5099.
    PubMed    


  144. CHETCUTI ZAMMIT S, McAlindon ME, Hale MF, Sidhu R, et al
    Isolated Terminal Ileitis: When Is It Not Crohn's Disease?
    Dig Dis Sci. 2018;63:1367.
    PubMed    


  145. MOGILEVSKI T, Sparrow MP
    Infliximab Versus Adalimumab in Patients with Biologic-Naive Crohn's Disease: Is the Difference Real?
    Dig Dis Sci. 2018;63:1094-1096.
    PubMed    


  146. BENMASSAOUD A, Al-Taweel T, Sasson MS, Moza D, et al
    Comparative Effectiveness of Infliximab Versus Adalimumab in Patients with Biologic-Naive Crohn's Disease.
    Dig Dis Sci. 2018;63:1302-1310.
    PubMed     Abstract available


    April 2018
  147. ANDERSON A, Ferris LK, Click B, Ramos-Rivers C, et al
    Low Rates of Dermatologic Care and Skin Cancer Screening Among Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2018 Apr 30. pii: 10.1007/s10620-018-5056.
    PubMed     Abstract available


  148. PERERA LP, Bhandari S, Liu R, Guilday C, et al
    Advanced Age Does Not Negatively Impact Health-Related Quality of Life in Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Apr 30. pii: 10.1007/s10620-018-5076.
    PubMed     Abstract available


  149. BAR-GIL SHITRIT A, Cohen Y, Hassin O, Ben Ya'acov A, et al
    Correction to: Antenatal Management for Women with Inflammatory Bowel Disease: Experience from Our 'IBD MOM' Clinic.
    Dig Dis Sci. 2018 Apr 27. pii: 10.1007/s10620-018-5084.
    PubMed     Abstract available


  150. SHAH R, Ho EY, Kramer JR, Richardson P, et al
    Hepatitis B Virus Screening and Reactivation in a National VA Cohort of Patients with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Antagonists.
    Dig Dis Sci. 2018 Apr 16. pii: 10.1007/s10620-018-5042.
    PubMed     Abstract available


  151. LIMSRIVILAI J, Rao K, Stidham RW, Govani SM, et al
    Systemic Inflammatory Responses in Ulcerative Colitis Patients and Clostridium difficile Infection.
    Dig Dis Sci. 2018 Apr 12. pii: 10.1007/s10620-018-5044.
    PubMed     Abstract available


  152. SHITRIT AB, Cohen Y, Hassin O, Ya'acov AB, et al
    Antenatal Management for Women with Inflammatory Bowel Disease: Experience from Our 'IBD MOM' Clinic.
    Dig Dis Sci. 2018 Apr 6. pii: 10.1007/s10620-018-5048.
    PubMed     Abstract available


  153. CAVOUNIDIS A, Uhlig HH
    Crohn's Disease in Niemann-Pick Disease Type C1: Caught in the Cross-Fire of Host-Microbial Interactions.
    Dig Dis Sci. 2018;63:811-813.
    PubMed    


  154. LING J, Buurman D, Ravikumara M, Mews C, et al
    Accelerated Step-Up Infliximab Use Is Associated with Sustained Primary Response in Pediatric Crohn's Disease.
    Dig Dis Sci. 2018;63:1003-1010.
    PubMed     Abstract available


  155. CICCONE F, Ciccone A, Di Ruscio M, Vernia F, et al
    IgG4-Related Disease Mimicking Crohn's Disease: A Case Report and Review of Literature.
    Dig Dis Sci. 2018;63:1072-1086.
    PubMed    


  156. NOBEL YR, Axelrad J, Lewis SK, Whittier S, et al
    Stool PCR for Gastrointestinal Pathogens in Patients With and Without Immune-Mediated Intestinal Diseases.
    Dig Dis Sci. 2018;63:996-1002.
    PubMed     Abstract available


  157. COUGNOUX A, Movassaghi M, Picache JA, Iben JR, et al
    Gastrointestinal Tract Pathology in a BALB/c Niemann-Pick Disease Type C1 Null Mouse Model.
    Dig Dis Sci. 2018;63:870-880.
    PubMed     Abstract available


    March 2018
  158. AVALOS DJ, Mendoza-Ladd A, Zuckerman MJ, Bashashati M, et al
    Hispanic Americans and Non-Hispanic White Americans Have a Similar Inflammatory Bowel Disease Phenotype: A Systematic Review with Meta-Analysis.
    Dig Dis Sci. 2018 Mar 29. pii: 10.1007/s10620-018-5022.
    PubMed     Abstract available


  159. CALDERA F, Saha S, Wald A, Garmoe CA, et al
    Lower Sustained Diphtheria and Pertussis Antibody Concentrations in Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2018 Mar 29. pii: 10.1007/s10620-018-5043.
    PubMed     Abstract available


  160. KERLIN AM, Long M, Kappelman M, Martin C, et al
    Profiles of Patients Who Use Marijuana for Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Mar 29. pii: 10.1007/s10620-018-5040.
    PubMed     Abstract available


  161. HOLMSTROM RB, Mogensen DV, Brynskov J, Ainsworth MA, et al
    Interactions Between Thiopurine Metabolites, Adalimumab, and Antibodies Against Adalimumab in Previously Infliximab-Treated Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Mar 21. pii: 10.1007/s10620-018-5020.
    PubMed     Abstract available


  162. BERRY N, Sinha SK, Bhattacharya A, Prasad KK, et al
    Role of Positron Emission Tomography in Assessing Disease Activity in Ulcerative Colitis: Comparison with Biomarkers.
    Dig Dis Sci. 2018 Mar 21. pii: 10.1007/s10620-018-5026.
    PubMed     Abstract available


  163. NISHIUMI S, Izumi Y, Yoshida M
    Alterations in Docosahexaenoic Acid-Related Lipid Cascades in Inflammatory Bowel Disease Model Mice.
    Dig Dis Sci. 2018 Mar 21. pii: 10.1007/s10620-018-5025.
    PubMed     Abstract available


  164. FABIAN O, Hradsky O, Drskova T, Mikus F, et al
    Immunohistochemical Assessment of CD30+ Lymphocytes in the Intestinal Mucosa Facilitates Diagnosis of Pediatric Ulcerative Colitis.
    Dig Dis Sci. 2018 Mar 14. pii: 10.1007/s10620-018-5018.
    PubMed     Abstract available


  165. KUSAKA J, Shiga H, Kuroha M, Kimura T, et al
    Residual Lesions on Capsule Endoscopy Is Associated with Postoperative Clinical Recurrence in Patients with Crohn's Disease.
    Dig Dis Sci. 2018;63:768-774.
    PubMed     Abstract available


  166. LUTHER J, Gala M, Patel SJ, Dave M, et al
    Loss of Response to Anti-Tumor Necrosis Factor Alpha Therapy in Crohn's Disease Is Not Associated with Emergence of Novel Inflammatory Pathways.
    Dig Dis Sci. 2018;63:738-745.
    PubMed     Abstract available


    February 2018
  167. FLEISHER M, Marsal J, Lee SD, Frado LE, et al
    Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Feb 26. pii: 10.1007/s10620-018-4971.
    PubMed     Abstract available


  168. MAK WY, Buisson A, Andersen MJ Jr, Lei D, et al
    Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis.
    Dig Dis Sci. 2018 Feb 22. pii: 10.1007/s10620-018-4980.
    PubMed     Abstract available


  169. KIELY CJ, Clark A, Bhattacharyya J, Moran GW, et al
    Acetarsol Suppositories: Effective Treatment for Refractory Proctitis in a Cohort of Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Feb 19. pii: 10.1007/s10620-017-4890.
    PubMed     Abstract available


  170. MATSUOKA K, Uemura Y, Kanai T, Kunisaki R, et al
    Efficacy of Bifidobacterium breve Fermented Milk in Maintaining Remission of Ulcerative Colitis.
    Dig Dis Sci. 2018 Feb 15. pii: 10.1007/s10620-018-4946.
    PubMed     Abstract available


  171. MICIC D, Yarur A, Gonsalves A, Rao VL, et al
    Risk Factors for Clostridium difficile Isolation in Inflammatory Bowel Disease: A Prospective Study.
    Dig Dis Sci. 2018 Feb 8. pii: 10.1007/s10620-018-4941.
    PubMed     Abstract available


    January 2018
  172. FERNANDEZ-BLANCO JI, Fernandez-Diaz G, Cara C, Vera MI, et al
    Adalimumab for Induction of Histological Remission in Moderately to Severely Active Ulcerative Colitis.
    Dig Dis Sci. 2018 Jan 25. pii: 10.1007/s10620-018-4935.
    PubMed     Abstract available


  173. BODEN EK, Shows DM, Chiorean MV, Lord JD, et al
    Identification of Candidate Biomarkers Associated with Response to Vedolizumab in Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Jan 25. pii: 10.1007/s10620-018-4924.
    PubMed     Abstract available


  174. LUKACH AJ, Saul MI, Ferris LK, Swoger JM, et al
    Risk Factors for Hidradenitis Suppurativa in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Jan 22. pii: 10.1007/s10620-018-4919.
    PubMed     Abstract available


  175. FEUERSTEIN JD, Curran T, Alosilla M, Cataldo T, et al
    Mortality Is Rare Following Elective and Non-elective Surgery for Ulcerative Colitis, but Mild Postoperative Complications Are Common.
    Dig Dis Sci. 2018 Jan 20. pii: 10.1007/s10620-018-4922.
    PubMed     Abstract available


  176. ANDRADE P, Lopes S, Gaspar R, Nunes A, et al
    Anti-Tumor Necrosis Factor-alpha-Induced Dermatological Complications in a Large Cohort of Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2018 Jan 18. pii: 10.1007/s10620-018-4921.
    PubMed     Abstract available


  177. PAPAMICHAEL K, Vajravelu RK, Osterman MT, Cheifetz AS, et al
    Long-Term Outcome of Infliximab Optimization for Overcoming Immunogenicity in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2018 Jan 16. pii: 10.1007/s10620-018-4917.
    PubMed     Abstract available


  178. OSAMURA A, Suzuki Y
    Fourteen-Year Anti-TNF Therapy in Crohn's Disease Patients: Clinical Characteristics and Predictive Factors.
    Dig Dis Sci. 2018;63:204-208.
    PubMed     Abstract available


  179. NGUYEN VQ, Mays JL, Lang M, Wu Y, et al
    Knowledge Gaps in the Management of Postoperative Crohn's Disease: A US National Survey.
    Dig Dis Sci. 2018;63:53-60.
    PubMed     Abstract available


    December 2017
  180. SHAMAH S, Schneider J, Korelitz BI
    High Incidence of Recurrent Crohn's Disease Following Colectomy for Ulcerative Colitis Revealed with Long Follow-Up.
    Dig Dis Sci. 2017 Dec 28. pii: 10.1007/s10620-017-4873.
    PubMed     Abstract available


  181. GIUFFRIDA P, Corazza GR, Di Sabatino A
    Old and New Lymphocyte Players in Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Dec 23. pii: 10.1007/s10620-017-4892.
    PubMed     Abstract available


    November 2017
  182. FEUERSTEIN JD, Papamichael K, Popejoy S, Nadelson A, et al
    Targeted Physician Education and Standardizing Documentation Improves Documented Reporting with Inflammatory Bowel Disease Quality Measures in a Large Academic and Private Practice.
    Dig Dis Sci. 2017 Nov 17. doi: 10.1007/s10620-017-4845.
    PubMed     Abstract available


  183. GURVITS GE
    Lax Prophylaxis: Vaccinating the Inflammatory Bowel Disease Patient.
    Dig Dis Sci. 2017 Nov 10. doi: 10.1007/s10620-017-4836.
    PubMed    


  184. FISCHER M, Campbell SC, Calley CSJ, Helper DJ, et al
    Risk Factors for Rescue Therapy in Crohn's Patients Maintained on Infliximab After Withdrawal of the Immunomodulator: A Long-Term Follow-Up.
    Dig Dis Sci. 2017;62:3131-3137.
    PubMed     Abstract available


  185. HAR-NOY O, Katz L, Avni T, Battat R, et al
    Chromoendoscopy, Narrow-Band Imaging or White Light Endoscopy for Neoplasia Detection in Inflammatory Bowel Diseases.
    Dig Dis Sci. 2017;62:2982-2990.
    PubMed     Abstract available


    October 2017
  186. MORSHEDZADEH N, Rahimlou M, Asadzadeh Aghdaei H, Shahrokh S, et al
    Association Between Adipokines Levels with Inflammatory Bowel Disease (IBD): Systematic Reviews.
    Dig Dis Sci. 2017 Oct 30. doi: 10.1007/s10620-017-4806.
    PubMed     Abstract available


  187. TSE CS, Deepak P, Smyrk TC, Raffals LE, et al
    Isolated Acute Terminal Ileitis Without Preexisting Inflammatory Bowel Disease Rarely Progresses to Crohn's Disease.
    Dig Dis Sci. 2017 Oct 24. doi: 10.1007/s10620-017-4803.
    PubMed     Abstract available


  188. FINE S, Nee J, Thakuria P, Duff B, et al
    Ocular, Auricular, and Oral Manifestations of Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Oct 24. doi: 10.1007/s10620-017-4781.
    PubMed     Abstract available


  189. CAMPBELL JP, Burton E, Wymer S, Shaw M, et al
    Out-of-Pocket Cost Is a Barrier to Therapeutic Drug Monitoring in Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Oct 20. doi: 10.1007/s10620-017-4808.
    PubMed     Abstract available


  190. CALLOWAY A, Dalal R, Beaulieu DB, Duley C, et al
    Depressive Symptoms Predict Anti-tumor Necrosis Factor Therapy Noncompliance in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Oct 20. doi: 10.1007/s10620-017-4800.
    PubMed     Abstract available


  191. DAI C, Jiang M, Sun MJ
    Fecal Calprotectin in Monitoring the Disease Activity in Colonic Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Oct 17. doi: 10.1007/s10620-017-4799.
    PubMed    


  192. LINARES PM, Algaba A, Urzainqui A, Guijarro-Rojas M, et al
    Ratio of Circulating Estrogen Receptors Beta and Alpha (ERbeta/ERalpha) Indicates Endoscopic Activity in Patients with Crohn's Disease.
    Dig Dis Sci. 2017;62:2744-2754.
    PubMed     Abstract available


  193. SEO H, Ye BD, Song EM, Lee SH, et al
    Long-Term Outcomes of Adalimumab Treatment in 254 Patients with Crohn's Disease: A Hospital-Based Cohort Study from Korea.
    Dig Dis Sci. 2017;62:2882-2893.
    PubMed     Abstract available


  194. LI J, Yan Y, Meng Z, Liu S, et al
    Microscopic Colitis Evolved Into Inflammatory Bowel Diseases Is Characterized by Increased Th1/Tc1 Cells in Colonic Mucosal Lamina Propria.
    Dig Dis Sci. 2017;62:2755-2767.
    PubMed     Abstract available


    September 2017
  195. PUOLANNE AM, Kolho KL, Alfthan H, Ristimaki A, et al
    Rapid Fecal Calprotectin Test and Symptom Index in Monitoring the Disease Activity in Colonic Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Sep 25. doi: 10.1007/s10620-017-4770.
    PubMed     Abstract available


  196. HUSSEY M, Holleran G, Smith S, Sherlock M, et al
    The Role and Regulation of the 11 Beta-Hydroxysteroid Dehydrogenase Enzyme System in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Sep 20. doi: 10.1007/s10620-017-4753.
    PubMed     Abstract available


  197. HAAS L, Chevalier R, Major BT, Enders F, et al
    Biologic Agents Are Associated with Excessive Weight Gain in Children with Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Sep 11. doi: 10.1007/s10620-017-4745.
    PubMed     Abstract available


  198. KUMAR V, Shah Y, Patel D, Khan N, et al
    Elderly-Onset and Adult-Onset Ulcerative Colitis Are More Similar than Previously Reported in a Nationwide Cohort.
    Dig Dis Sci. 2017 Sep 7. doi: 10.1007/s10620-017-4734.
    PubMed     Abstract available


  199. DE BARROS KSC, Flores C, Harlacher L, Francesconi CFM, et al
    Evolution of Clinical Behavior in Crohn's Disease: Factors Associated with Complicated Disease and Surgery.
    Dig Dis Sci. 2017;62:2481-2488.
    PubMed     Abstract available


  200. BELLOLIO ROTH F, Gomez J, Cerda J
    Increase in Hospital Discharges for Inflammatory Bowel Diseases in Chile Between 2001 and 2012.
    Dig Dis Sci. 2017;62:2311-2317.
    PubMed     Abstract available


  201. SHAH A, Talley NJ, Walker M, Koloski N, et al
    Is There a Link Between H. Pylori and the Epidemiology of Crohn's Disease?
    Dig Dis Sci. 2017;62:2472-2480.
    PubMed     Abstract available


    August 2017
  202. CASTANEDA G, Liu B, Torres S, Bhuket T, et al
    Race/Ethnicity-Specific Disparities in the Severity of Disease at Presentation in Adults with Ulcerative Colitis: A Cross-Sectional Study.
    Dig Dis Sci. 2017 Aug 30. doi: 10.1007/s10620-017-4733.
    PubMed     Abstract available


  203. POURAFKARI L, Masnadi-Shirazi K, Taban M, Mohammadi S, et al
    Higher Frequency of Nocturnal Blood Pressure Dipping but Not Heart Rate Dipping in Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Aug 23. doi: 10.1007/s10620-017-4712.
    PubMed     Abstract available


  204. PHAM HV, Hasan I, Udaltsova N, Pham K, et al
    Rates and Predictors of Vaccinations Among Inflammatory Bowel Disease Patients Receiving Anti-Tumor Necrosis Factor Agents.
    Dig Dis Sci. 2017 Aug 23. doi: 10.1007/s10620-017-4716.
    PubMed     Abstract available


  205. ZIZZO MG, Serio R
    Therapeutic Potential of the Gabaergic System in Ulcerative Colitis: Current Status and Perspectives.
    Dig Dis Sci. 2017 Aug 5. doi: 10.1007/s10620-017-4709.
    PubMed    


  206. CARRASCO A, Fernandez-Banares F
    Th1 Pathway: The Missing Link Between Inflammatory Bowel Disease and Microscopic Colitis?
    Dig Dis Sci. 2017 Aug 3. doi: 10.1007/s10620-017-4692.
    PubMed    


  207. ALLOCCA M, Fiorino G, Danese S
    Biosimilar Drugs for Inflammatory Bowel Disease: Is Similar Good Enough?
    Dig Dis Sci. 2017 Aug 3. doi: 10.1007/s10620-017-4693.
    PubMed    


  208. KAMAT N, Ganesh Pai C, Surulivel Rajan M, Kamath A, et al
    Cost of Illness in Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Aug 1. doi: 10.1007/s10620-017-4690.
    PubMed     Abstract available


  209. BAFFORD AC, Latushko A, Hansraj N, Jambaulikar G, et al
    The Use of Temporary Fecal Diversion in Colonic and Perianal Crohn's Disease Does Not Improve Outcomes.
    Dig Dis Sci. 2017;62:2079-2086.
    PubMed     Abstract available


  210. JEWEL SAMADDER N, Valentine JF, Guthery S, Singh H, et al
    Colorectal Cancer in Inflammatory Bowel Diseases: A Population-Based Study in Utah.
    Dig Dis Sci. 2017;62:2126-2132.
    PubMed     Abstract available


    July 2017
  211. MOURAD FH, Yau Y, Wasinger VC, Leong RW, et al
    Proteomics in Inflammatory Bowel Disease: Approach Using Animal Models.
    Dig Dis Sci. 2017 Jul 17. doi: 10.1007/s10620-017-4673.
    PubMed     Abstract available


  212. SARTINI A, Gitto S, Villa E
    Does Metabolic Syndrome and Not the Inflammatory Load Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients?
    Dig Dis Sci. 2017 Jul 4. doi: 10.1007/s10620-017-4665.
    PubMed    


    June 2017
  213. AGGARWAL S, Ahuja V, Paul J
    Attenuated GABAergic Signaling in Intestinal Epithelium Contributes to Pathogenesis of Ulcerative Colitis.
    Dig Dis Sci. 2017 Jun 30. doi: 10.1007/s10620-017-4662.
    PubMed     Abstract available


  214. SMITS LJT, Grelack A, Derikx LAAP, de Jong DJ, et al
    Long-Term Clinical Outcomes After Switching from Remicade(R) to Biosimilar CT-P13 in Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Jun 30. doi: 10.1007/s10620-017-4661.
    PubMed     Abstract available


  215. ARGUELLES-ARIAS F, Guerra Veloz MF, Perea Amarillo R, Vilches-Arenas A, et al
    Erratum to: Effectiveness and Safety of CT-P13 (Biosimilar Infliximab) in Patients with Inflammatory Bowel Disease in Real Life at 6 Months.
    Dig Dis Sci. 2017 Jun 28. doi: 10.1007/s10620-017-4657.
    PubMed    


  216. KIM ES, Kim KO, Jang BI, Kim EY, et al
    Comparison of 4-L Polyethylene Glycol and 2-L Polyethylene Glycol Plus Ascorbic Acid in Patients with Inactive Ulcerative Colitis.
    Dig Dis Sci. 2017 Jun 21. doi: 10.1007/s10620-017-4634.
    PubMed     Abstract available


  217. ELURI S, Parian AM, Limketkai BN, Ha CY, et al
    Nearly a Third of High-Grade Dysplasia and Colorectal Cancer Is Undetected in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Jun 19. doi: 10.1007/s10620-017-4652.
    PubMed     Abstract available


  218. LIU L, Li X
    NLRP3 Inflammasome in Inflammatory Bowel Disease: Friend or Foe?
    Dig Dis Sci. 2017 Jun 19. doi: 10.1007/s10620-017-4650.
    PubMed    


  219. JUNG YS, Han M, Kim WH, Park S, et al
    Incidence and Clinical Outcomes of Inflammatory Bowel Disease in South Korea, 2011-2014: A Nationwide Population-Based Study.
    Dig Dis Sci. 2017 Jun 7. doi: 10.1007/s10620-017-4640.
    PubMed     Abstract available


  220. FRIEDMAN S
    Gestational Weight Gain: A New Factor Influencing Pregnancy Outcomes in Women with Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Jun 2. doi: 10.1007/s10620-017-4635.
    PubMed    


  221. LI J, Ueno A, Iacucci M, Fort Gasia M, et al
    Crossover Subsets of CD4+ T Lymphocytes in the Intestinal Lamina Propria of Patients with Crohn's Disease and Ulcerative Colitis.
    Dig Dis Sci. 2017 Jun 1. doi: 10.1007/s10620-017-4596.
    PubMed     Abstract available


  222. CAMPOS C, Perrey A, Lambert C, Pereira B, et al
    Medical Therapies for Stricturing Crohn's Disease: Efficacy and Cross-Sectional Imaging Predictors of Therapeutic Failure.
    Dig Dis Sci. 2017;62:1628-1636.
    PubMed     Abstract available


  223. OBI K, Hinton A, Sobotka L, Levine E, et al
    Hospital-Acquired Conditions Are Associated with Worse Outcomes in Crohn's Disease-Related Hospitalizations.
    Dig Dis Sci. 2017;62:1621-1627.
    PubMed     Abstract available


  224. NAFTALI T, Mechulam R, Marii A, Gabay G, et al
    Low-Dose Cannabidiol Is Safe but Not Effective in the Treatment for Crohn's Disease, a Randomized Controlled Trial.
    Dig Dis Sci. 2017;62:1615-1620.
    PubMed     Abstract available


  225. KIM JW, Lee HS, Ye BD, Yang SK, et al
    Incidence of and Risk Factors for Free Bowel Perforation in Patients with Crohn's Disease.
    Dig Dis Sci. 2017;62:1607-1614.
    PubMed     Abstract available


  226. FUMERY M, Kohut M, Gower-Rousseau C, Duhamel A, et al
    Incidence, Clinical Presentation, and Associated Factors of Microscopic Colitis in Northern France: A Population-Based Study.
    Dig Dis Sci. 2017;62:1571-1579.
    PubMed     Abstract available


    May 2017
  227. MILLER TL, Lee D, Giefer M, Wahbeh G, et al
    Nutritional Therapy in Very Early-Onset Inflammatory Bowel Disease: A Case Report.
    Dig Dis Sci. 2017 May 27. doi: 10.1007/s10620-017-4616.
    PubMed     Abstract available


  228. TASSON L, Canova C, Vettorato MG, Savarino E, et al
    Influence of Diet on the Course of Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 May 26. doi: 10.1007/s10620-017-4620.
    PubMed     Abstract available


  229. RINAWI F, Assa A, Bashir H, Peleg S, et al
    Clinical and Phenotypic Differences in Inflammatory Bowel Disease Among Arab and Jewish Children in Israel.
    Dig Dis Sci. 2017 May 25. doi: 10.1007/s10620-017-4623.
    PubMed     Abstract available


  230. ZULLOW S, Jambaulikar G, Rustgi A, Quezada S, et al
    Risk Factors for Vitamin D Deficiency and Impact of Repletion in a Tertiary Care Inflammatory Bowel Disease Population.
    Dig Dis Sci. 2017 May 25. doi: 10.1007/s10620-017-4614.
    PubMed     Abstract available


  231. LAZARIDIS LD, Pistiki A, Giamarellos-Bourboulis EJ, Georgitsi M, et al
    Activation of NLRP3 Inflammasome in Inflammatory Bowel Disease: Differences Between Crohn's Disease and Ulcerative Colitis.
    Dig Dis Sci. 2017 May 18. doi: 10.1007/s10620-017-4609.
    PubMed     Abstract available


    April 2017
  232. MEIGHANI A, Hart BR, Bourgi K, Miller N, et al
    Outcomes of Fecal Microbiota Transplantation for Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Apr 27. doi: 10.1007/s10620-017-4580.
    PubMed     Abstract available


  233. SAEZ-GONZALEZ E, Moret I, Alvarez-Sotomayor D, Diaz-Jaime FC, et al
    Immunological Mechanisms of Adsorptive Cytapheresis in Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Apr 21. doi: 10.1007/s10620-017-4577.
    PubMed     Abstract available


  234. JIANG Y, Lin O, Sinha SR
    Use of Tumor Necrosis Factor Alpha Inhibitors for Inflammatory Bowel Disease Patients with Concurrent Heart Failure.
    Dig Dis Sci. 2017 Apr 17. doi: 10.1007/s10620-017-4574.
    PubMed     Abstract available


  235. PIECHOTA-POLANCZYK A, Wlodarczyk M, Sobolewska-Wlodarczyk A, Jonakowski M, et al
    Serum Cyclophilin A Correlates with Increased Tissue MMP-9 in Patients with Ulcerative Colitis, but Not with Crohn's Disease.
    Dig Dis Sci. 2017 Apr 8. doi: 10.1007/s10620-017-4568.
    PubMed     Abstract available


  236. CAO B, Zhou X, Ma J, Zhou W, et al
    Role of MiRNAs in Inflammatory Bowel Disease.
    Dig Dis Sci. 2017 Apr 8. doi: 10.1007/s10620-017-4567.
    PubMed     Abstract available


  237. BARTELS LE, Dahlerup JF
    Association of Helicobacter pylori and Crohn's Disease Incidence: An Inversion Reaction?
    Dig Dis Sci. 2017 Apr 5. doi: 10.1007/s10620-017-4561.
    PubMed    


  238. ULLMAN TA, Itzkowitz SH
    Prognosis of Colorectal Cancer in Inflammatory Bowel Disease: Data from a State Registry.
    Dig Dis Sci. 2017 Apr 3. doi: 10.1007/s10620-017-4557.
    PubMed    


  239. HIRTEN R, Sands BE, Cohen BL
    The Whys and Hows of Fourth-Year Inflammatory Bowel Disease Fellowships.
    Dig Dis Sci. 2017 Apr 1. doi: 10.1007/s10620-017-4555.
    PubMed    


  240. SOFIA MA, Rubin DT
    The Impact of Therapeutic Antibodies on the Management of Digestive Diseases: History, Current Practice, and Future Directions.
    Dig Dis Sci. 2017;62:833-842.
    PubMed     Abstract available


  241. BENET-CAMPOS C, Cuellar C, Garcia-Ballesteros C, Zamora V, et al
    Determination of Anti-Anisakis Simplex Antibodies and Relationship with alphabeta and gammadelta Lymphocyte Subpopulations in Patients with Crohn's Disease.
    Dig Dis Sci. 2017;62:934-943.
    PubMed     Abstract available


  242. CAO Y, Ding Z, Han C, Shi H, et al
    Efficacy of Mesenchymal Stromal Cells for Fistula Treatment of Crohn's Disease: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2017;62:851-860.
    PubMed     Abstract available


  243. KAUNITZ JD
    Development of Monoclonal Antibodies: The Dawn of mAb Rule.
    Dig Dis Sci. 2017;62:831-832.
    PubMed    


    March 2017
  244. ALLEGRETTI JR, Barnes EL, Stevens B, Storm M, et al
    Predictors of Clinical Response and Remission at 1 Year Among a Multicenter Cohort of Patients with Inflammatory Bowel Disease Treated with Vedolizumab.
    Dig Dis Sci. 2017 Mar 29. doi: 10.1007/s10620-017-4549.
    PubMed     Abstract available


  245. BENGTSON MB, Martin CF, Aamodt G, Vatn MH, et al
    Inadequate Gestational Weight Gain Predicts Adverse Pregnancy Outcomes in Mothers with Inflammatory Bowel Disease: Results from a Prospective US Pregnancy Cohort.
    Dig Dis Sci. 2017 Mar 22. doi: 10.1007/s10620-017-4547.
    PubMed     Abstract available


  246. KHAN N, Patel D, Shah Y, Yang YX, et al
    A Novel Model for Predicting Incident Moderate to Severe Anemia and Iron Deficiency in Patients with Newly Diagnosed Ulcerative Colitis.
    Dig Dis Sci. 2017 Mar 11. doi: 10.1007/s10620-017-4512.
    PubMed     Abstract available


  247. ARGUELLES-ARIAS F, Guerra Veloz MF, Perea Amarillo R, Vilches-Arenas A, et al
    Effectiveness and Safety of CT-P13 (Biosimilar Infliximab) in Patients with Inflammatory Bowel Disease in Real Life at 6 Months.
    Dig Dis Sci. 2017 Mar 9. doi: 10.1007/s10620-017-4511.
    PubMed     Abstract available


  248. CARR RM, Patel A, Bownik H, Oranu A, et al
    Intestinal Inflammation Does Not Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2017 Mar 6. doi: 10.1007/s10620-017-4495.
    PubMed     Abstract available


  249. BOLTIN D, Kamenetsky Z, Perets TT, Snir Y, et al
    Circulating Bone Marrow-Derived CD45-/CD34+/CD133+/VEGF+ Endothelial Progenitor Cells in Adults with Crohn's Disease.
    Dig Dis Sci. 2017;62:633-638.
    PubMed     Abstract available


  250. DIETRICH C, Singh SR
    Circulating Endothelial Progenitor Cells in Crohn's Disease: An EPiC in the Making?
    Dig Dis Sci. 2017;62:567-568.
    PubMed    


  251. TRIADAFILOPOULOS G, Eisenstat S, Dormady S, Sinha R, et al
    When It Rains It Pours: Evolving, Complicated Small Intestinal Crohn's Disease.
    Dig Dis Sci. 2017;62:577-582.
    PubMed    


    February 2017
  252. RAI T, Choudhury BN, Kedia S, Bopanna S, et al
    Short-Term Clinical Response to Corticosteroids Can Predict Long-Term Natural History of Ulcerative Colitis: Prospective Study Experience.
    Dig Dis Sci. 2017 Feb 4. doi: 10.1007/s10620-017-4450.
    PubMed     Abstract available


  253. NARULA N, Cooray M, Anglin R, Muqtadir Z, et al
    Impact of High-Dose Vitamin D3 Supplementation in Patients with Crohn's Disease in Remission: A Pilot Randomized Double-Blind Controlled Study.
    Dig Dis Sci. 2017;62:448-455.
    PubMed     Abstract available


  254. BODELIER AG, Jonkers D, van den Heuvel T, de Boer E, et al
    High Percentage of IBD Patients with Indefinite Fecal Calprotectin Levels: Additional Value of a Combination Score.
    Dig Dis Sci. 2017;62:465-472.
    PubMed     Abstract available


  255. KOTZE PG, Saab MP, Saab B, da Silva Kotze LM, et al
    Tumor Necrosis Factor Alpha Inhibitors Did Not Influence Postoperative Morbidity After Elective Surgical Resections in Crohn's Disease.
    Dig Dis Sci. 2017;62:456-464.
    PubMed     Abstract available


    January 2017
  256. SCAIOLI E, Sartini A, Liverani E, Digby RJ, et al
    Sulfasalazine in Prevention of Pouchitis After Proctocolectomy with Ileal Pouch-Anal Anastomosis for Ulcerative Colitis.
    Dig Dis Sci. 2017 Jan 21. doi: 10.1007/s10620-017-4454.
    PubMed     Abstract available


  257. LEE HS, Lim YJ, Shim KN, Moon CM, et al
    Diagnostic Value of Small Bowel Capsule Endoscopy in Isolated Ileitis: A CAPENTRY Study.
    Dig Dis Sci. 2017;62:180-187.
    PubMed     Abstract available


  258. SRIDHAR A, Cwiak CA, Kaunitz AM, Allen RH, et al
    Contraceptive Considerations for Women with Gastrointestinal Disorders.
    Dig Dis Sci. 2017;62:54-63.
    PubMed     Abstract available


  259. STEVENS BW, Borren NZ, Velonias G, Conway G, et al
    Vedolizumab Therapy Is Associated with an Improvement in Sleep Quality and Mood in Inflammatory Bowel Diseases.
    Dig Dis Sci. 2017;62:197-206.
    PubMed     Abstract available


  260. FORTINSKY KJ, Kevans D, Qiang J, Xu W, et al
    Rates and Predictors of Endoscopic and Clinical Recurrence After Primary Ileocolic Resection for Crohn's Disease.
    Dig Dis Sci. 2017;62:188-196.
    PubMed     Abstract available


  261. XIE M, Qin H, Luo Q, He X, et al
    Comparison of Adipose-Derived and Bone Marrow Mesenchymal Stromal Cells in a Murine Model of Crohn's Disease.
    Dig Dis Sci. 2017;62:115-123.
    PubMed     Abstract available


  262. REGALIA K, Shelton A, Berry G, Triadafilopoulos G, et al
    Pulmonary Crohn's Disease.
    Dig Dis Sci. 2017;62:64-67.
    PubMed    


    December 2016
  263. TAKAHARA I, Takeshima F, Ichikawa T, Matsuzaki T, et al
    Prevalence of Restless Legs Syndrome in Patients with Inflammatory Bowel Disease.
    Dig Dis Sci. 2016 Dec 29. doi: 10.1007/s10620-016-4420.
    PubMed     Abstract available


  264. KORELITZ BI
    Enduring Value of Thiopurines for Inflammatory Bowel Disease Therapy.
    Dig Dis Sci. 2016 Dec 26. doi: 10.1007/s10620-016-4419.
    PubMed    


  265. TAN MC, El-Serag HB, Hou JK
    Determinants of Healthcare Utilization Among Veterans with Inflammatory Bowel Disease.
    Dig Dis Sci. 2016 Dec 23. doi: 10.1007/s10620-016-4414.
    PubMed     Abstract available


  266. BERNSTEIN GR, Pickett-Blakely O
    De Novo Inflammatory Bowel Disease After Bariatric Surgery: A Case Series and Literature Review.
    Dig Dis Sci. 2016 Dec 23. doi: 10.1007/s10620-016-4412.
    PubMed    


  267. TAXONERA C, Iglesias E, Munoz F, Calvo M, et al
    Adalimumab Maintenance Treatment in Ulcerative Colitis: Outcomes by Prior Anti-TNF Use and Efficacy of Dose Escalation.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


  268. FEUERSTEIN JD, Sehgal P, Rao V, Malladi VR, et al
    Inflammatory Bowel Disease-Related Abstracts Presented at National Conferences in the USA Are Frequently Unpublished as Full Manuscripts.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


  269. WANNHOFF A, Rupp C, Friedrich K, Knierim J, et al
    Carcinoembryonic Antigen Level in Primary Sclerosing Cholangitis Is Not Influenced by Dominant Strictures or Bacterial Cholangitis.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


    November 2016
  270. PRIEUX-KLOTZ C, Nahon S, Amiot A, Sinayoko L, et al
    Rate and Predictors of Mucosal Healing in Ulcerative Colitis Treated with Thiopurines: Results of a Multicentric Cohort Study.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


  271. LOPEZ-SANROMAN A, Carpio D, Calvet X, Romero C, et al
    Perceived Emotional and Psychological Impact of Ulcerative Colitis on Outpatients in Spain: UC-LIFE Survey.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


    October 2016
  272. PADHAN RK, Kedia S, Garg SK, Bopanna S, et al
    Long-Term Disease Course and Pregnancy Outcomes in Women with Inflammatory Bowel Disease: An Indian Cohort Study.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


  273. LATUSHKO A, Ghazi LJ
    A Case of Thiopurine-Induced Acute Myocarditis in a Patient with Ulcerative Colitis.
    Dig Dis Sci. 2016.
    PubMed    


  274. COLOM-STEELE D, Castresana D, Hanson J, Parasher G, et al
    A Rare Case of Invasive Pancreatitis in an Immunocompromised Host.
    Dig Dis Sci. 2016.
    PubMed    


    September 2016
  275. BARNES EL, Goldin A, Winter RW, Collins E, et al
    Sequential Combination Therapy Versus Monotherapy: A Lack of Benefit in Time to Inflammatory Bowel Disease-Related Surgery.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


  276. SUSKIND DL, Wahbeh G, Cohen SA, Damman CJ, et al
    Patients Perceive Clinical Benefit with the Specific Carbohydrate Diet for Inflammatory Bowel Disease.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


  277. ANDERSON AJ, Click B, Ramos-Rivers C, Babichenko D, et al
    Development of an Inflammatory Bowel Disease Research Registry Derived from Observational Electronic Health Record Data for Comprehensive Clinical Phenotyping.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


    April 2016
  278. LIU JJ, Kay TM, Davis EM, Lou Y, et al
    Epithelial Cell Extrusion Zones Observed on Confocal Laser Endomicroscopy Correlates with Immunohistochemical Staining of Mucosal Biopsy Samples.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


  279. LEE D, Suskind D
    Individualized Food-Based Dietary Therapy for Crohn's Disease: Are We Making Progress?
    Dig Dis Sci. 2016;61:958-60.
    PubMed    


    March 2016
  280. PAUL S, Shuja A, Tam I, Kim EM, et al
    Gastroenterologists Have Suboptimal Hepatitis B Virus Screening Rates in Patients Receiving Immunosuppressive Therapy.
    Dig Dis Sci. 2016.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: